The U.S. Food and Drug Administration (FDA) has approved Gazyva® (obinutuzumab), developed by Genentech, as a treatment for adults with lupus nephritis (LN), also known as lupus-related kidney disease ...
Certain graphics on this page may be affected by ad-blocking software. If portions of the page appear blank and an ad blocker is enabled, please disable the ad blocker and refresh the page to ensure ...
While safety is comparable between the treatments, the efficacy of PCL is superior to that of PLLA for the treatment of nasolabial fold wrinkles.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback